Close Menu

NEW YORK (360Dx) – Abcam has agreed to work with Chinese diagnostics firm Shuwen Biotech on the development and commercialization of companion diagnostics, the companies announced today.

The scope of the partnership has yet to be determined, but is expected to involve Abcam providing reproducible, highly specific recombinant antibodies against key targets, which Shuwen will incorporate into CDx kits.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.